Jana K. HoffmaninMahana TherapeuticsMind the Gut with Dr. Alice SibelliAlice Sibelli was one of Mahana’s early hires and worked for 10 years in health psychology before joining the startup world.Mar 24, 2021Mar 24, 2021
Jana K. HoffmaninMahana TherapeuticsMahana Therapeutics Obtains CE Mark for Parallel™ in the UKParallel is a prescription digital therapeutic that addresses IBS symptoms.Mar 11, 2021Mar 11, 2021
Jana K. HoffmaninMahana TherapeuticsMahana Therapeutics Obtains FDA Marketing Authorization for the First Prescription Digital…Company announces industry veteran Steven Basta joining as CEODec 8, 2020Dec 8, 2020
Jana K. HoffmaninMahana TherapeuticsMind the Gut: A Q&A with Dr. Emeran MayerDr. Emeran Mayer explains brain-gut interactions, the affects on Irritable Bowel Syndrome and the benefits of Cognitive Behavioral Therapy.Sep 25, 2020Sep 25, 2020
Jana K. HoffmaninMahana TherapeuticsThe Benefits of Prescription Digital Therapeutics for Gastrointestinal ConditionsPrescription digital therapeutics (PDTs) have the potential to vastly improve life outcomes for millions of people.May 28, 2020May 28, 2020